Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 262 Specimen Handling 253 pembrolizumab 230 Cyclophosphamide 216 Radiotherapy 204 Nivolumab 168 Cisplatin 161 Carboplatin 145 Biopsy 144 Radiosurgery 128 fludarabine 123 Blood Specimen Collection 116 Gemcitabine 111 Paclitaxel 107 Surveys and Questionnaires 106 Standard of Care 102 venetoclax 94 Dexamethasone 93 Bevacizumab 92 Radiation 87 Rituximab 81 Capecitabine 80 Cytarabine 79 Oxaliplatin 77 Drug Therapy 75 Doxorubicin 75 Ipilimumab 73 durvalumab 70 fludarabine phosphate 69 atezolizumab 68

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Diarylheptanoids × 90 days × Clear all

NCT06626230 2026-05-18

Safety of Anal Curcumin

Emory University

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡